These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 22841687

  • 21. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
    Mochizuki A, Komatsuzaki Y, Shoji S.
    Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
    [Abstract] [Full Text] [Related]

  • 22. Lewy body disease and dementia. A review.
    Kalra S, Bergeron C, Lang AE.
    Arch Intern Med; 1996 Mar 11; 156(5):487-93. PubMed ID: 8604954
    [Abstract] [Full Text] [Related]

  • 23. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K, Takahashi H.
    Nihon Rinsho; 2000 Oct 11; 58(10):2022-7. PubMed ID: 11068441
    [Abstract] [Full Text] [Related]

  • 24. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
    Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM.
    Mov Disord; 2017 Mar 11; 32(3):423-432. PubMed ID: 27911006
    [Abstract] [Full Text] [Related]

  • 25. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, Schapira AH.
    J Neurol Sci; 1998 Jun 11; 158(1):24-9. PubMed ID: 9667773
    [Abstract] [Full Text] [Related]

  • 26. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
    Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C, Shah K, Mash DC, Masliah E, Sidhu A.
    PLoS One; 2013 Jun 11; 8(9):e75025. PubMed ID: 24073234
    [Abstract] [Full Text] [Related]

  • 27. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Grochowska MM, Carreras Mascaro A, Boumeester V, Natale D, Breedveld GJ, Geut H, van Cappellen WA, Boon AJW, Kievit AJA, Sammler E, Netherlands Brain Bank, Parchi P, Cortelli P, Alessi DR, van de Berg WDJ, Bonifati V, Mandemakers W.
    Acta Neuropathol; 2021 Jul 11; 142(1):117-137. PubMed ID: 33913039
    [Abstract] [Full Text] [Related]

  • 28. Degeneration of the centré median-parafascicular complex in Parkinson's disease.
    Henderson JM, Carpenter K, Cartwright H, Halliday GM.
    Ann Neurol; 2000 Mar 11; 47(3):345-52. PubMed ID: 10716254
    [Abstract] [Full Text] [Related]

  • 29. [An autopsy case of senile dementia with pathological features of Parkinson's disease].
    Oshima K, Tsuchiya K, Iritani S, Niizato K, Akiyama H, Ikeda K, Arai H.
    No To Shinkei; 2004 Jul 11; 56(7):603-6. PubMed ID: 15379289
    [Abstract] [Full Text] [Related]

  • 30. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K.
    Neurosci Lett; 2010 Dec 03; 486(1):19-23. PubMed ID: 20851165
    [Abstract] [Full Text] [Related]

  • 31. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Jellinger KA.
    Parkinsonism Relat Disord; 2006 Mar 03; 12(2):119-20. PubMed ID: 16337163
    [No Abstract] [Full Text] [Related]

  • 32. The neuromythology of Parkinson's Disease.
    Calne DB, Mizuno Y.
    Parkinsonism Relat Disord; 2004 Jul 03; 10(5):319-22. PubMed ID: 15196512
    [Abstract] [Full Text] [Related]

  • 33. Neuropathology of dementia in a large cohort of patients with Parkinson's disease.
    Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kövari E.
    Parkinsonism Relat Disord; 2013 Oct 03; 19(10):864-8; discussion 864. PubMed ID: 23746454
    [Abstract] [Full Text] [Related]

  • 34. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H, Wakabayashi K.
    Parkinsonism Relat Disord; 2005 Jun 03; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H.
    J Neurochem; 2004 Oct 03; 91(2):451-61. PubMed ID: 15447678
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.